Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
A comparison of borderline personality disorder with and without eating disorders
Psychiatry Research, 10/27/09
Chen EY et al. – In the BPD sample, in the last year, current BN was associated with a significantly greater risk of recurrent suicide attempts while current AN was associated with increased risk of recurrent non–suicidal self–injury. BPD with current AN or BED was associated with a greater number of non–ED current Axis I disorders.
Today in Eating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
The Outcome of Bulimia Nervosa: Findings From One-Quarter Century of Research
American Journal of Psychiatry, 11/06/09
Randomized Controlled Clinical Trial of Yoga in the Treatment of Eating Disorders
Journal of Adolescent Health, 11/04/09
Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa
European Journal of Endocrinology, 11/05/09
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Today in Personality Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Impulsivity, personality and bipolar disorder
European Psychiatry , 11/06/09
Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder
International Clinical Psychopharmacology, 10/23/09
Sponsor
Article Search
Sponsor


See All



